Cencora, Inc. (COR)
NYSE: COR · Real-Time Price · USD
335.64
-0.41 (-0.12%)
Oct 28, 2025, 4:00 PM EDT - Market closed
Cencora Revenue
Cencora had revenue of $80.66B in the quarter ending June 30, 2025, with 8.65% growth. This brings the company's revenue in the last twelve months to $316.65B, up 11.56% year-over-year. In the fiscal year ending September 30, 2024, Cencora had annual revenue of $293.96B with 12.12% growth.
Revenue (ttm)
$316.65B
Revenue Growth
+11.56%
P/S Ratio
0.21
Revenue / Employee
$6,883,791
Employees
46,000
Market Cap
65.07B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 293.96B | 31.79B | 12.12% |
| Sep 30, 2023 | 262.17B | 23.59B | 9.89% |
| Sep 30, 2022 | 238.59B | 24.60B | 11.50% |
| Sep 30, 2021 | 213.99B | 24.09B | 12.69% |
| Sep 30, 2020 | 189.89B | 10.30B | 5.74% |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 56.37B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
COR News
- 12 days ago - IntrinsiQ Specialty Solutions Expands Data Capabilities to Empower Biopharmaceutical Manufacturers and Physicians with Actionable Insights to Improve Patient Outcomes - Business Wire
- 14 days ago - The Market Took a Hit. These 6 Stocks Can Sidestep the Wreckage. - Barrons
- 22 days ago - Cencora Announces Date and Time for Fourth Quarter Fiscal 2025 Earnings Release - Business Wire
- 6 weeks ago - Cencora, Inc. (COR) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript) - Seeking Alpha
- 7 weeks ago - Cencora, Inc. (COR) Presents At Baird Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 7 weeks ago - Cencora, Inc. (COR) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript - Seeking Alpha
- 2 months ago - Cencora Appoints Mark Durcan as Chairman of Its Board of Directors - Business Wire
- 2 months ago - Cencora: Yet Another Strong Quarter, But Valuations Still Aren't Cheap - Seeking Alpha